Home | HealthCare Royalty Partners

Advancing Biopharmaceutical Innovation with Creative Capital Solutions

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy

Click here for press release

Royalty Monetization

Corporate Financing

$7B+

Committed in more than 110 biopharma products since inception

NY

New York Metro Area

CA

San Francisco

MA

Boston

UK

London

33

Team Members*

Meet Our Team

Team

Interview with Dr. Robert Langer, HCRx Senior Advisor

Interview with Gary Lyons, HCRx Senior Advisor

Interview with Dr. Greg Went, Former Chairman & CEO, Adamas Pharmaceuticals (December 2017)

Interview with Julie McHugh, HCRx Senior Advisor

Interview with Julie Anne Smith, Former President and CEO, Raptor Pharmaceuticals

Interview with Nat Ricciardi, HCRx Senior Advisor

Spotlight

Latest News

HealthCare Royalty Announces Royalty Monetization Agreement for Modeyso® Commercial Royalties

Apnimed Secures Up to $150 Million in Debt Financing with HealthCare Royalty Partners to Support Planned AD109 Commercial Launch

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

Duke Professor Reinvests Royalties into New Research

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy

BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty

REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

*The HCRx team comprises 33 individuals (including the Senior Advisor Board and Regional Advisors).